Princeton Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Princeton Capital Management LLC

  • $302 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$8.03 - $11.7 $50,990 - $74,295
-6,350 Closed
0 $0
Q1 2019

May 02, 2019
SELL
$7.72 - $12.81 $3,860 - $6,405
-500 Reduced 7.3%
6,350 $61,000
Q4 2018

Feb 13, 2019
SELL
$9.51 - $16.6 $9,510 - $16,600
-1,000 Reduced 12.74%
6,850 $79,000
Q1 2018

May 03, 2018
BUY
$16.7 - $26.35 $131,095 - $206,847
7,850 New
7,850 $149,000

Others Institutions Holding SGMO

# of Institutions
133
Shares Held
86.4M
Call Options Held
35.9K
Put Options Held
156K
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $124M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Princeton Capital Management LLC Portfolio

Follow Princeton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email